Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults

Clinical trial NCT07295028 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07295028
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lower Respiratory Tract Disease Healthy Participants

Start date: 2025-11-17
Primary completion: 2026-04-21
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.